Cover Image
市場調查報告書

全球流感疫苗市場分析與預測

Influenza Vaccines Market & Forecast - Worldwide Analysis

出版商 Renub Research 商品編碼 227787
出版日期 內容資訊 英文 179 Pages; 140 Figures & 7 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
全球流感疫苗市場分析與預測 Influenza Vaccines Market & Forecast - Worldwide Analysis
出版日期: 2014年11月14日 內容資訊: 英文 179 Pages; 140 Figures & 7 Tables
簡介

認識的提高,新興各國的疫苗接種率的增加,政府對季節性流感的疫苗接種支援的擴大等,成為活化流感疫苗市場的主要促進要素。季節性流感疫苗市場2013年達數十億美元的市場規模。該市場預計2013年到2019年以兩位數的比例成長。

本報告提供全球流感疫苗市場現況與展望調查分析、市場規模的變化與預測、各地區/國家、流感類型、主要疫苗品牌類型詳細內容、市場成長的各種推進因素分析、主要經營者的收益、企業分析等彙整。

第1章 摘要整理

第2章 全球流感疫苗市場與預測

  • 全球:接種季節性流感疫苗的人數
  • 流感疫苗市場上的M&A

第3章 全球:季節性流感疫苗市場與預測

第4章 全球:豬(H1N1)流感疫苗市場

第5章 全球流感疫苗市場佔有率與預測

  • 各市場區隔:流感疫苗市場佔有率與預測
  • 各國:接種季節性流感疫苗的人數比例、佔有率與預測
  • 各國:季節性流感疫苗市場佔有率與預測
  • :
  • 第6章 地區區分季節性流感疫苗市場、疫苗接種率
  • 美國
  • 日本
  • 中國
  • 印度
  • 巴西
  • 荷蘭
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 丹麥
  • 瑞典
  • 葡萄牙
  • 盧森堡
  • 立陶宛
  • 英國
  • 波蘭
  • 挪威
  • 羅馬尼亞
  • 愛沙尼亞
  • 芬蘭
  • 匈牙利
  • 愛爾蘭
  • 冰島
  • 拉脫維亞
  • 馬爾他
  • 斯洛伐克
  • 斯洛維尼亞
  • 澳洲
  • 紐西蘭

第7章 全球:季節性流感疫苗品牌的銷售額與預測

  • Fluarix/Flulaval:銷售額實際成果與預測
  • Afluria/Fluvax:銷售額實際成果與預測
  • FluMist/Fluenz:銷售額實際成果與預測
  • Influvac (Abbott收購):銷售額實際成果與預測
  • Fluvirin / Flucelvax:銷售額實際成果與預測
  • Fluzone:銷售額實際成果與預測

第8章 流感疫苗市場的促進因素

  • 疫苗技術的轉換
  • 對有效的通訊策略的持續性焦點
  • 疫苗疾病預防最符合成本效益的方式
  • 化學、技術性成功
  • 歐洲各國的季節性流感、疫苗接種相關教育,訓練及資訊交流的推動

第9章 流感疫苗市場課題

  • 在最大限度活用已經過核准疫苗時的障礙
  • 流感疫苗開發、認證制度的困難
  • 疫苗開發計劃的縮短
  • 在疫苗接種中醫護人員面臨的問題

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.

Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.

United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.

In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.

This is 2nd edition report on Influenza Vaccines by Renub Research. Research study titled "Influenza Vaccines Market & Forecast - Worldwide Analysis" provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market

  • Worldwide Influenza vaccines market (2009 - 2019)
  • Worldwide Seasonal Influenza vaccines market has been covered from (2009 - 2019)
  • Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 - 2011)
  • Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
  • Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
  • Top 30 countries Seasonal Influenza vaccines market (2008 - 2019)
  • Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax, FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast
  • Top Merger & Acquisition deals in Influenza Vaccines Market
  • Key drivers of growth in the Worldwide Influenza Vaccines Market
  • Key challenges faces by Influenza Vaccines Market

All the 30 Countries Studied in the Report are as Follows

  • 1. United States
  • 2. Japan
  • 3. China
  • 4. India
  • 5. Brazil
  • 6. Netherlands
  • 7. Germany
  • 8. France
  • 9. Italy
  • 10. Spain
  • 11. Denmark
  • 12. Sweden
  • 13. Portugal
  • 14. Luxembourg
  • 15. Lithuania
  • 16. United Kingdom
  • 17. Poland
  • 18. Norway
  • 19. Romania
  • 20. Estonia
  • 21. Finland
  • 22. Hungary
  • 23. Ireland
  • 24. Iceland
  • 25. Latvia
  • 26. Malta
  • 27. Slovakia
  • 28. Slovenia
  • 29. Australia
  • 30. New Zealand

Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

  • 1. Fluarix / Flulaval
  • 2. Afluria/Fluvax
  • 3. FluMist/Fluenz
  • 4. Influvac
  • 5. Fluvirin / Flucelvax
  • 6. Fluzone
  • Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Influenza Vaccines Market & Forecast

  • 2.1 Worldwide - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
  • 2.2 Merger and Acquisition in Influenza Vaccines Market

3. Worldwide - Seasonal Influenza Vaccines Market & Forecast

4. Worldwide - Swine Flu (H1N1) Influenza Vaccines Market

5. Worldwide Influenza Vaccines Market Share & Forecast

  • 5.1 Segment wise - Influenza Vaccines Market Share & Forecast
  • 5.2 Countries wise - Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share & Forecast
  • 5.3 Countries wise - Seasonal Influenza Vaccines Market Share & Forecast

6. Geographical Segmentation - Seasonal Influenza Vaccines Market & Vaccination Coverage (2008 - 2019)

  • 6.1 United States
    • 6.1.1 United States - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.1.2 United States - Seasonal Influenza Vaccines Market & Forecast
  • 6.2 Japan
    • 6.2.1 Japan - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.2.2 Japan - Seasonal Influenza Vaccines Market & Forecast
  • 6.3 China
    • 6.3.1 China - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.3.2 China - Seasonal Influenza Vaccines Market & Forecast
  • 6.4 India
    • 6.4.1 India - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.4.2 India - Seasonal Influenza Vaccines Market & Forecast
  • 6.5 Brazil
    • 6.5.1 Brazil - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.5.2 Brazil - Seasonal Influenza Vaccines Market & Forecast
  • 6.6 Netherlands
    • 6.6.1 Netherlands - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.6.2 Netherlands - Seasonal Influenza Vaccines Market & Forecast
  • 6.7 Germany
    • 6.7.1 Germany - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.7.2 Germany - Seasonal Influenza Vaccines Market & Forecast
  • 6.8 France
    • 6.8.1 France - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.8.2 France - Seasonal Influenza Vaccines Market & Forecast
  • 6.9 Italy
    • 6.9.1 Italy - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.9.2 Italy - Seasonal Influenza Vaccines Market & Forecast
  • 6.10 Spain
    • 6.10.1 Spain - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.10.2 Spain - Seasonal Influenza Vaccines Market & Forecast
  • 6.11 Denmark
    • 6.11.1 Denmark - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.11.2 Denmark - Seasonal Influenza Vaccines Market & Forecast
  • 6.12 Sweden
    • 6.12.1 Sweden - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.12.2 Sweden - Seasonal Influenza Vaccines Market & Forecast
  • 6.13 Portugal
    • 6.13.1 Portugal - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.13.2 Portugal - Seasonal Influenza Vaccines Market & Forecast
  • 6.14 Luxembourg
    • 6.14.1 Luxembourg - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.14.2 Luxembourg - Seasonal Influenza Vaccines Market & Forecast
  • 6.15 Lithuania
    • 6.15.1 Lithuania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.15.2 Lithuania - Seasonal Influenza Vaccines Market & Forecast
  • 6.16 United Kingdom
    • 6.16.1 United Kingdom - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.16.2 United Kingdom - Seasonal Influenza Vaccines Market & Forecast
  • 6.17 Poland
    • 6.17.1 Poland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.17.2 Poland - Seasonal Influenza Vaccines Market & Forecast
  • 6.18 Norway
    • 6.18.1 Norway - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.18.2 Norway - Seasonal Influenza Vaccines Market & Forecast
  • 6.19 Romania
    • 6.19.1 Romania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.19.2 Romania - Seasonal Influenza Vaccines Market & Forecast
  • 6.20 Estonia
    • 6.20.1 Estonia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.20.2 Estonia - Seasonal Influenza Vaccines Market & Forecast
  • 6.21 Finland
    • 6.21.1 Finland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.21.2 Finland - Seasonal Influenza Vaccines Market & Forecast
  • 6.22 Hungary
    • 6.22.1 Hungary - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.22.2 Hungary - Seasonal Influenza Vaccines Market & Forecast
  • 6.23 Ireland
    • 6.23.1 Ireland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.23.2 Ireland - Seasonal Influenza Vaccines Market & Forecast
  • 6.24 Iceland
    • 6.24.1 Iceland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.24.2 Iceland - Seasonal Influenza Vaccines Market & Forecast
  • 6.25 Latvia
    • 6.25.1 Latvia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.25.2 Latvia - Seasonal Influenza Vaccines Market & Forecast
  • 6.26 Malta
    • 6.26.1 Malta - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.26.2 Malta - Seasonal Influenza Vaccines Market & Forecast
  • 6.27 Slovakia
    • 6.27.1 Slovakia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.27.2 Slovakia - Seasonal Influenza Vaccines Market & Forecast
  • 6.28 Slovenia
    • 6.28.1 Slovenia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.28.2 Slovenia - Seasonal Influenza Vaccines Market & Forecast
  • 6.29 Australia
    • 6.29.1 Australia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.29.2 Australia - Seasonal Influenza Vaccines Market & Forecast
  • 6.30 New Zealand
    • 6.30.1 New Zealand - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.30.2 New Zealand - Seasonal Influenza Vaccines Market & Forecast

7. Worldwide - Seasonal Influenza Vaccine Brand Sales & Forecast

  • 7.1 Fluarix / Flulaval - Sales Performance & Forecast
  • 7.2 Afluria/Fluvax - Sales Performance & Forecast
  • 7.3 FluMist/Fluenz - Sales Performance & Forecast
  • 7.4 Influvac (Now Acquired by Abbott) - Sales Performance & Forecast
  • 7.5 Fluvirin / Flucelvax - Sales Performance & Forecast
  • 7.6 Fluzone - Sales Performance & Forecast

8. Growth Drivers in the Influenza Vaccines Market

  • 8.1 Transforming Vaccine Technologies
  • 8.2 Continuous Focus on Effective Communication Strategies
  • 8.3 Vaccines most Cost Effective Means of Disease Prevention
  • 8.4 Scientific & Technological Breakthroughs
  • 8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in European Countries

9. Challenges for Influenza Vaccine Market

  • 9.1 Obstacle to Best Possible use of Licensed Vaccines
    • 9.1.1 Economic Obstacles
    • 9.1.2 Technical Obstacles
    • 9.1.3 Cultural Obstacles
  • 9.2 Difficulty of Influenza Vaccine Development & Approval System
    • 9.2.1 General Technical Barriers
    • 9.2.2 Economic Barriers
    • 9.2.3 Legal Barriers
    • 9.2.4 Regulatory Barriers
  • 9.3 Reducing the Timeline for Vaccine Development
  • 9.4 Problem Faced by Healthcare Workers in Immunization

LIST OF FIGURES

  • Figure 2 1: Worldwide - Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 2 2: Worldwide - Forecast for Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 2 3: Worldwide - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 - 2013
  • Figure 2 4: Worldwide - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 - 2019
  • Figure 3 1: Worldwide - Seasonal Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 3 2: Worldwide - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 4 1: Worldwide - Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 - 2011
  • Figure 5 1: Segment wise - Influenza Vaccines Market Share (Percent), 2009 - 2013
  • Figure 5 2: Segment wise - Forecast for Influenza Vaccines Market Share (Percent), 2014 - 2019
  • Figure 6 1: United States - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 - 2013
  • Figure 6 2: United States - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 3: United States - Seasonal Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 6 4: United States - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 5: Japan - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 6: Japan - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 7: Japan - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 8: Japan - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 9: China - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008-2013
  • Figure 6 10: China - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 11: China - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 12: China - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 13: India - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 14: India - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 15: India - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 16: India - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 17: Brazil - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 18: Brazil - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 19: Brazil - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 20: Brazil - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 21: Netherlands - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 22: Netherlands - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 23: Netherlands - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 24: Netherlands - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 25: Germany - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 26: Germany - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 27: Germany - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 28: Germany - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 29: France - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 30: France - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 31: France - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 32: France - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 33: Italy - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 34: Italy - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 35: Italy - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 36: Italy - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 37: Spain - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 38: Spain - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 39: Spain - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 40: Spain - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 41: Denmark - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 42: Denmark - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 43: Denmark - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 44: Denmark - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 45: Sweden - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 46: Sweden - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 47: Sweden - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 48: Sweden - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 49: Portugal - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 50: Portugal - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 51: Portugal - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 52: Portugal - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 53: Luxembourg - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 54: Luxembourg - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 55: Luxembourg - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 56: Luxembourg - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 57: Lithuania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 58: Lithuania - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 59: Lithuania - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 60: Lithuania - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 61: United Kingdom - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 62: United Kingdom - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 63: United Kingdom - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 64: United Kingdom - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 65: Poland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 66: Poland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 67: Poland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 68: Poland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 69: Norway - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 70: Norway - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 71: Norway - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 72: Norway - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 73: Romania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 74: Romania - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 75: Romania - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 76: Romania - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 77: Estonia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 78: Estonia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 79: Estonia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 80: Estonia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 81: Finland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 82: Finland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 83: Finland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 84: Finland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 85: Hungary - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 86: Hungary - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 87: Hungary - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 88: Hungary - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 89: Ireland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008-2013
  • Figure 6 90: Ireland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 91: Ireland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 92: Ireland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 93: Iceland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 94: Iceland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 95: Iceland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 96: Iceland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 97: Latvia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 98: Latvia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 99: Latvia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 100: Latvia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 101: Malta - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 102: Malta - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 103: Malta - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 104: Malta - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 105: Slovakia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 106: Slovakia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 107: Slovakia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 108: Slovakia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 109: Slovenia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 110: Slovenia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 111: Slovenia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 112: Slovenia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 113: Australia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 114: Australia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 115: Australia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 116: Australia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 117: New Zealand - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 118: New Zealand - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 119: New Zealand - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 120: New Zealand - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 7 1: Worldwide - Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 - 2013
  • Figure 7 2: Worldwide - Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 3: Worldwide - Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 - 2013
  • Figure 7 4: Worldwide - Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 5: Worldwide - Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 - 2013
  • Figure 7 6: Worldwide - Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 7: Worldwide - Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 - 2009
  • Figure 7 8: Worldwide - Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 - 2013
  • Figure 7 9: Worldwide - Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 10: Worldwide - Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 - 2013
  • Figure 7 11: Worldwide - Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 - 2019

LIST OF TABLES

  • Table 2 1: Worldwide - Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 - 2011
  • Table 5 1: Countries wise - Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 - 2013
  • Table 5 2: Countries wise - Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 - 2019
  • Table 5 3: Countries wise - Seasonal Influenza Vaccines Market Share (Percent), 2009 - 2013
  • Table 5 4: Countries wise - Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 - 2019
  • Table 8 1: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Table 8 2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Back to Top